Citadel Advisors’s Aravive, Inc. Common Stock ARAV Stock Holding History

Citadel Advisors’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,100	Closed	-$1.73K	–	15546
2023 Q3	$1.73K	Buy	+13,100	New	+$8.23K	﹤0.01%	13817
2023 Q2	–	Sell	-6,700	Closed	-$13.4K	–	15533
2023 Q1	$13.4K	Sell	6,700 -12,600	-65%	-$23.7K	﹤0.01%	13366
2022 Q4	$25.5K	Buy	+19,300	New	+$24.6K	﹤0.01%	12926
2021 Q4	–	Sell	-14,700	Closed	-$55K	–	15068
2021 Q3	$55K	Sell	14,700 -79,500	-84%	-$339K	﹤0.01%	13325
2021 Q2	$563K	Buy	+94,200	New	+$498K	﹤0.01%	9796
2020 Q1	–	Sell	-11,700	Closed	-$160K	–	10362
2019 Q4	$160K	Sell	11,700 -2,300	-16%	-$20.3K	﹤0.01%	8328
2019 Q3	$105K	Buy	+14,000	New	+$87.3K	﹤0.01%	8467
2018 Q1	–	Sell	-4,317	Closed	-$57K	–	8930
2017 Q4	$57K	Sell	4,317 -12,433	-74%	-$160K	﹤0.01%	7594
2017 Q3	$246K	Buy	16,750 +14,717	+724%	+$1.48M	﹤0.01%	6371
2017 Q2	$213K	Buy	+2,033	New	+$218K	﹤0.01%	6476

Other funds holding ARAV

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors's ARAV Position: Q3 2023 in Review

Citadel Advisors sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2023, closing a stake of 107,555 shares — an estimated $67.6K sold.

Citadel Advisors first reported a position in ARAV in Q1 2014 and held it in 21 quarters. The position peaked at $3.94M in Q3 2015. 33 funds tracked by Wall St. Rank hold ARAV as of Q3 2023.

Citadel Advisors reported no remaining Aravive, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Citadel Advisors sold 107,555 Aravive, Inc. Common Stock shares in Q3 2023, an estimated $67.6K.
Citadel Advisors first reported a position in Aravive, Inc. Common Stock in Q1 2014 and held it in 21 quarters.
Citadel Advisors's Aravive, Inc. Common Stock position peaked at $3.94M in Q3 2015.
33 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.